Company news

Delcath Systems, Inc. news in 2021

Delcath Systems, Inc.'s news releases, calls and decks from 2021, newest first.

View company

Delcath Systems, Inc. Announces Positive Phase 3 FOCUS Trial Results for Hepzato™ in Liver-Dominant Metastatic Ocular Melanoma, Including Initial Survival Data Analysis

December 1, 2021

Delcath Systems Provides Speaker List for Dec 2, 2021 Investor Update Meeting

November 29, 2021

Delcath Systems Announces Third Quarter 2021 Results

November 8, 2021

Delcath Systems to Hold Investor Update on Focus Trial Data and Future Development Plans on December 2, 2021

November 4, 2021

Delcath Systems Schedules Conference Call to Report 2021 Third Quarter Financial Results

October 24, 2021

Delcath Systems Announces Second Quarter 2021 Results

August 9, 2021

Delcath Systems Secures Up to a $20.0 Million Debt Facility with Avenue Venture Opportunities Fund, L.P.

August 8, 2021

Delcath Systems Schedules Conference Call to Report 2021 Second Quarter Financial Results

July 27, 2021

Delcath Systems, Inc. Announces First Quarter 2021 Results

May 10, 2021

Delcath Systems Schedules Conference Call to Report 2021 First Quarter Financial Results

April 29, 2021

Delcath Systems Announces Oral Presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting

April 29, 2021

Delcath Systems, Inc. Announces Revised NICE Guidance for CHEMOSAT in the United Kingdom

April 20, 2021

Delcath Systems, Inc. Shares Additional Information Regarding FOCUS Trial Power Calculation

March 30, 2021

Delcath Systems, Inc. Announces Positive Preliminary Results from Phase 3 FOCUS Trial of HEPZATO in Patients with Metastatic Ocular Melanoma

March 30, 2021

Delcath Systems, Inc. Announces Fourth Quarter 2020 Results, Highlights Preliminary Positive FOCUS Trial Results; Conference Call Today at 8: 00am Eastern Time

March 30, 2021

Delcath Systems Schedules Conference Call to Report 2020 Fourth Quarter Financial Results

March 23, 2021

Calls in 2021

Decks in 2021